Changes in Mamillopontine Distance and Pontomesencephalic angle following Treatment for Pediatric Idiopathic

Sadullah Şimşek1, Tülin Savaş2, Tarık Sağlam1

  • 1Diyarbakır SBU Gazi Yaşargil Training and Research Hospital, Radiology Department, Turkey, Diyarbakır.

Klinische Padiatrie
|July 13, 2026
PubMed

Insights

Pediatric idiopathic intracranial hypertension (IIH) can be monitored using MRI measurements. The mammillopontine distance and pontomesencephalic angle show significant changes after treatment, making them useful markers for follow-up.

Area of Science:

  • Neurology
  • Radiology
  • Pediatrics

Background:

  • Pediatric idiopathic intracranial hypertension (IIH) lacks objective, noninvasive markers for diagnosis and monitoring.
  • Current diagnostic and follow-up methods for pediatric IIH can be invasive or subjective.

Purpose of the Study:

  • To evaluate if mammillopontine distance and pontomesencephalic angle, measured via MRI, reflect treatment-related changes in pediatric IIH.
  • To determine the utility of these measurements as potential objective markers for IIH management.

Main Methods:

  • A retrospective study involving 40 children (20 with pediatric IIH, 20 controls) aged 5-15 years.
  • MRI scans were performed before and after treatment for pediatric IIH patients, and serially for controls.
  • Mammillopontine distance and pontomesencephalic angle were measured on sagittal T2-weighted images by three radiologists.

Main Results:

  • Pediatric IIH patients had significantly lower mammillopontine distance and pontomesencephalic angle compared to controls before treatment.
  • Following treatment (lumbar puncture, acetazolamide), both mammillopontine distance and pontomesencephalic angle significantly increased.
  • The pontomesencephalic angle demonstrated a more pronounced change post-treatment, suggesting higher responsiveness.

Conclusions:

  • Mammillopontine distance and pontomesencephalic angle are reproducible MRI markers that reflect treatment-related changes in pediatric IIH.
  • These measurements show potential as objective, noninvasive tools for monitoring treatment response and disease progression in pediatric IIH.
  • The pontomesencephalic angle may be a more sensitive indicator for tracking treatment efficacy compared to mammillopontine distance.
Abstract

Related Concept Videos

Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...